Integra Lifesciences Holdings Corp

IART

Market Cap$2.61B

Close$

Compare Integra Lifesciences Holdings

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Integra Lifesciences Holdings Corp	38.5	0%	4%	1.7	0.9
Market Avg	59.7	1.27%	30%	-	0.9
Healthcare Avg	64.5	1.29%	15%	7.1	0.8

$35.64

Current Fair Value

11.2% upside

Undervalued by 11.2% based on the discounted cash flow analysis.

Share Statistics

Market cap	$2.61 Billion
Enterprise Value	$3.80 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$0.84
Beta	1.38
Outstanding Shares	78,602,240
Avg 30 Day Volume	685,716

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	38.47
PEG	-61.51
Price to Sales	1.69
Price to Book Ratio	1.6
Enterprise Value to Revenue	2.46
Enterprise Value to EBIT	34.04
Enterprise Value to Net Income	56
Total Debt to Enterprise	0.4
Debt to Equity	0.94

Revenue Sources

No data

ESG Score

No data

About Integra Lifesciences Holdings Corp

CEO: Peter Arduini